ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neurology

Top Neurology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HASAN MOUSLI MD

Neurology

4,741

$339K

436
217 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $204

CARLOS RAMIREZ-CALDERON M.D.

Neurology

4,683

$1.52M

505
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$324
Average prescription price

Avg: $204

DEAN SUTHERLAND MD

Neurology

4,657

$1.02M

615
561 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$218
Average prescription price

Avg: $204

SADAF BAZARGAN MD

Neurology

4,547

$559K

114
34 are 65+

65%
patients receiving schedule two controlled substances

Avg: 4%

32%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$123
Average prescription price

Avg: $204

RHAISA DUMENIGO MD

Neurology

4,515

$340K

455
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $204

SHRINATH KAMAT MD PA

Neurology

4,492

$563K

533
316 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$125
Average prescription price

Avg: $204

ALVARO LACAYO MD

Neurology

4,412

$604K

257
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $204

JAYANTH BOLARAM M.D.

Neurology

4,388

$465K

536
237 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$106
Average prescription price

Avg: $204

GEORGE DMYTRENKO M.D., PH.D.

Neurology

4,312

$1.1M

481
266 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$255
Average prescription price

Avg: $204

ANETTE NIEVES MD

Neurology

4,130

$673K

487
439 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$163
Average prescription price

Avg: $204

MICHELLE DOMPENCIEL M.D.

Neurology

4,102

$322K

1145
1043 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $204

STUART SHAFER MD

Neurology

4,094

$1.9M

462
356 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$465
Average prescription price

Avg: $204

RAFAEL RODRIGUEZ MD

Neurology

4,090

$823K

693
534 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$201
Average prescription price

Avg: $204

VICTOR MAQUERA MD

Neurology

4,027

$1.65M

299
152 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$409
Average prescription price

Avg: $204

PETER ALDANA MD

Neurology

3,994

$873K

468
283 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$219
Average prescription price

Avg: $204

WINSTON ORTIZ MD

Neurology

3,776

$967K

365
198 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$256
Average prescription price

Avg: $204

JOHN AXLEY M.D.

Neurology

3,693

$292K

134
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $204

JOSE MUNOZ M.D.

Neurology

3,690

$181K

837
758 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $204

MICHAEL NOVAK M.D.

Neurology

3,680

$556K

451
378 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$151
Average prescription price

Avg: $204

BRIDGLAL RAMKISSOON M.D.

Neurology

3,679

$388K

582
499 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$106
Average prescription price

Avg: $204

ANNE ROTTMANN MD

Neurology

3,678

$882K

355
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$240
Average prescription price

Avg: $204

JEREMY GRIMES MD

Neurology

3,668

$531K

466
270 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 27%

$145
Average prescription price

Avg: $204

SIDDHARTH SHAH M.D.

Neurology

3,653

$883K

562
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$242
Average prescription price

Avg: $204

DANIEL ROSS D.O.

Neurology

3,643

$834K

348
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$229
Average prescription price

Avg: $204

DELVIS CELDRAN M.D.

Neurology

3,643

$386K

363
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$106
Average prescription price

Avg: $204

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank